Pol. Merkur. Lek (Pol. Med. J.), 2020, XLVIII/288: 427-430 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2020, XLVIII/288: 427-430

Title: The level of stress and the assessment of selected clinical parameters in patients with androgenetic alopecia

Authors: Kozicka K, Łukasik A, Jaworek A, Pastuszczak M, Spałkowska M, Kłosowicz A, Dyduch G, Wojas-Pelc A. 


More details


0,00 zł


The level of stress and the assessment of selected clinical parameters in patients with androgenetic alopecia

Kozicka K1, Łukasik A1, Jaworek A1, Pastuszczak M1, Spałkowska M1, Kłosowicz A1, Dyduch G2, Wojas-Pelc A1.

Jagiellonian University, Collegium Medicum, Cracow, Poland: 1Department of Dermatology; 2Department of Pathomorphology

Androgenetic alopecia is the most common type of hair loss both in male as well as female patients. It is a type of non-cicatricial hair loss. Pathophysiology of the disease remains largely unknown. It is believed that the occurrence of FPHL (female pattern hair loss) is linked with cellular insensitivity to androgens. Human hair does not only represent beauty, health and youth, but it also has a significant impact on one’s self-esteem. For many patients, hair loss is a stigmatizing experience, many of them complain about a lower quality of life, anxiety or even depression.
Aim of the study
was to evaluate the levels of selected clinical parameters, including exposure to stress and disease progression based on the Ludwig scale, and of the applied therapies in a group of female patients with androgenetic alopecia.
Material and methods
. A group of 106 patients with androgenetic alopecia was analyzed with respect to their age, duration of disease, disease progression based on the Ludwig scale, family history of AGA, exposure to stress (with the level of stress subjectively assessed by the patients using a score of 1 to 10), and treatment modality. Comparison of the results will be carried out with the help of the Statistica software, using the Student’s t-test or its non-parametric equivalent.
. Patients reported very high levels of stress exposure: 7 and 8 on a scale of 1 to 10. The type of treatment applied (local vs. systemic) was of no significance with respect to the alleviation of stress. Disease progression was not found to correlate with the level of stress. When analyzing disease progression, using the Ludwig classification scale, most of the patients met the criteria of type I-2 (24.74%). As regards the comparison of treatment modalities in the study group, a great majority of patients was treated with topical agents in the form of scalp massage liquids (80.00%), while 17.14% of the study population underwent systemic treatment. A small percentage of patients also resorted to esthetic medicine procedures (3.81%), and 22.86% of them used dietary supplements or OTC topical agents.
High levels of stress exposure reported by patients most probably stemmed from the symptoms of the disease itself, as the study population was quite diverse in terms of their levels of professional activity and the type of profession performed.

Key words: androgenetic alopecia, AGA, FPHL, QoL, stress

Pol Med J, 2020; XLVIII (288); 427–430